Allmed Solutions (ALMD.TA) Stock Price

Allmed Solutions Price

CLOSED
33.20ILS-0.70 (-2.09 %)
Market closed

Over the last 9 years Allmed Solutions grew revenue by 8.5% annually, reaching 5.55 M ILS. Earnings per share have declined at 53.2% per year over the last 4 years. For Allmed Solutions, the net margin of 50.6% is up versus -294.4% a few years ago. The stock trades about 14% above its 52-week low.

Allmed Solutions stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Allmed Solutions over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Allmed Solutions stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Allmed Solutions's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Allmed Solutions Stock Price History
DateAllmed Solutions Price
8/3/202633.20 ILS
7/31/202633.90 ILS
7/30/202633.90 ILS
7/29/202632.90 ILS
7/28/202631.00 ILS
7/27/202630.20 ILS
7/24/202631.00 ILS
7/22/202630.10 ILS
7/21/202631.70 ILS
7/20/202631.70 ILS
7/17/202631.00 ILS
7/16/202632.60 ILS
7/15/202632.60 ILS
7/14/202633.90 ILS
7/13/202633.90 ILS
7/10/202633.90 ILS
7/9/202633.90 ILS
7/8/202633.80 ILS
7/7/202634.30 ILS
7/6/202633.80 ILS
7/3/202633.80 ILS
7/2/202633.80 ILS
7/1/202633.80 ILS
6/30/202631.50 ILS
6/29/202631.20 ILS
6/26/202631.20 ILS
6/25/202631.20 ILS
6/24/202631.20 ILS
6/23/202631.40 ILS
6/22/202632.30 ILS
6/19/202633.50 ILS
6/18/202633.50 ILS
6/17/202633.50 ILS
6/16/202633.50 ILS
6/15/202633.50 ILS
6/12/202633.50 ILS
6/11/202632.00 ILS
6/10/202632.00 ILS
6/9/202632.10 ILS
6/8/202632.10 ILS
6/5/202633.40 ILS
6/4/202633.50 ILS
6/3/202633.50 ILS
6/2/202632.60 ILS
6/1/202634.40 ILS
5/29/202634.20 ILS
5/28/202631.80 ILS
5/27/202633.40 ILS
5/26/202634.90 ILS
5/25/202634.70 ILS
5/22/202632.00 ILS
5/21/202632.00 ILS
5/20/202632.00 ILS
5/19/202634.50 ILS
5/18/202635.90 ILS
5/15/202635.50 ILS
5/14/202631.70 ILS
5/13/202631.70 ILS
5/12/202632.10 ILS
5/11/202633.50 ILS
5/8/202633.50 ILS
5/7/202633.50 ILS
5/6/202633.80 ILS
5/5/202635.50 ILS
5/4/202635.50 ILS
5/1/202635.50 ILS
4/30/202636.30 ILS
4/29/202631.90 ILS
4/28/202632.60 ILS
4/27/202634.50 ILS
4/24/202634.40 ILS
4/23/202634.40 ILS
4/22/202634.00 ILS
4/21/202634.00 ILS
4/20/202634.00 ILS
4/17/202634.90 ILS
4/16/202634.90 ILS
4/15/202634.90 ILS
4/14/202636.50 ILS
4/13/202636.50 ILS
4/10/202635.80 ILS
4/9/202635.80 ILS
4/6/202635.90 ILS
4/3/202636.70 ILS
3/31/202635.60 ILS
3/30/202633.40 ILS
3/27/202634.90 ILS
3/26/202635.00 ILS
3/25/202635.00 ILS
3/23/202636.10 ILS
3/19/202637.70 ILS
3/17/202637.70 ILS
3/16/202637.70 ILS
3/13/202636.60 ILS
3/12/202638.50 ILS
3/11/202639.60 ILS
3/10/202638.70 ILS
3/9/202635.70 ILS
3/5/202640.50 ILS
3/4/202638.60 ILS
3/2/202639.30 ILS
2/27/202639.10 ILS
2/26/202637.00 ILS
2/25/202634.20 ILS
2/24/202634.70 ILS
2/23/202634.20 ILS
2/20/202636.30 ILS
2/19/202637.30 ILS
2/18/202638.00 ILS
2/17/202637.80 ILS
2/16/202637.50 ILS
2/13/202637.60 ILS
2/12/202636.80 ILS
2/11/202637.20 ILS
2/10/202637.00 ILS
2/9/202637.90 ILS
2/6/202635.70 ILS
2/5/202635.90 ILS
2/4/202634.00 ILS
2/3/202635.80 ILS
2/2/202636.60 ILS
1/29/202636.10 ILS
1/28/202636.30 ILS
1/27/202635.60 ILS
1/26/202635.00 ILS
1/23/202635.90 ILS
1/22/202633.60 ILS
1/20/202633.20 ILS
1/19/202633.40 ILS
1/16/202634.10 ILS
1/15/202634.00 ILS
1/14/202634.20 ILS
1/13/202633.00 ILS
1/12/202633.30 ILS
1/9/202633.50 ILS
1/8/202631.40 ILS
1/7/202631.50 ILS
1/6/202633.10 ILS
1/5/202633.80 ILS
1/1/202634.00 ILS
12/31/202534.70 ILS
12/30/202530.90 ILS
12/29/202531.80 ILS
12/28/202532.20 ILS
12/25/202532.70 ILS
12/24/202533.40 ILS
12/23/202533.00 ILS
12/22/202533.40 ILS
12/21/202535.00 ILS
12/18/202534.10 ILS
12/17/202535.50 ILS
12/16/202535.20 ILS
12/15/202535.90 ILS
12/14/202535.50 ILS
12/11/202534.30 ILS
12/10/202535.20 ILS
12/9/202532.90 ILS
12/8/202534.30 ILS
12/7/202533.40 ILS
12/4/202532.90 ILS
12/3/202531.30 ILS
12/2/202530.00 ILS
12/1/202529.50 ILS
11/30/202529.20 ILS
11/27/202529.00 ILS
11/26/202529.60 ILS
11/25/202530.00 ILS
11/24/202529.80 ILS
11/23/202531.00 ILS
11/20/202531.60 ILS
11/19/202531.50 ILS
11/18/202531.60 ILS
11/17/202532.30 ILS
11/16/202531.60 ILS
11/13/202532.00 ILS
11/12/202532.00 ILS
11/11/202532.00 ILS
11/10/202530.60 ILS
11/9/202530.90 ILS
11/6/202530.70 ILS
11/5/202531.10 ILS
11/3/202530.80 ILS
10/28/202531.90 ILS
10/27/202532.00 ILS
10/26/202531.80 ILS
10/23/202533.10 ILS
10/22/202532.00 ILS
10/21/202532.90 ILS
10/20/202531.90 ILS
10/19/202532.00 ILS
10/16/202531.80 ILS
10/15/202532.60 ILS
10/12/202532.90 ILS
10/9/202533.20 ILS
10/8/202533.40 ILS
10/5/202534.00 ILS
9/30/202533.10 ILS
9/28/202533.70 ILS
9/25/202533.00 ILS
9/15/202533.50 ILS
9/10/202533.90 ILS
9/9/202534.40 ILS
9/8/202533.70 ILS
9/7/202534.00 ILS
9/3/202531.90 ILS
9/2/202531.90 ILS
9/1/202533.60 ILS
8/31/202534.50 ILS
8/28/202532.00 ILS
8/27/202534.40 ILS
8/26/202532.20 ILS
8/25/202532.10 ILS
8/24/202529.20 ILS
8/21/202530.30 ILS
8/20/202530.30 ILS
8/19/202529.90 ILS
8/18/202531.40 ILS
8/12/202532.40 ILS
8/11/202532.30 ILS
8/7/202531.90 ILS
Access this data via the Eulerpool API
Get Free API Key

Allmed Solutions Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
7.70 M ILS
-22.84 M ILS
-22.68 M ILS
Jan 1, 2018
9.28 M ILS
-22.93 M ILS
-20.18 M ILS
Jan 1, 2019
11.15 M ILS
22.72 M ILS
21.99 M ILS
Jan 1, 2020
9.72 M ILS
-5.93 M ILS
-8.66 M ILS
Jan 1, 2021
5.55 M ILS
6.24 M ILS
2.81 M ILS
Jan 1, 2022
0.00 ILS
-12.41 M ILS
-12.14 M ILS
Jan 1, 2023
0.00 ILS
-3.34 M ILS
1.42 M ILS
Jan 1, 2024
0.00 ILS
-11.07 M ILS
-8.75 M ILS

Allmed Solutions Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 9:57 AM
 
REVENUEM ILS
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM ILS
EBITM ILS
EBIT MARGIN%
NET INCOMEM ILS
NET INCOME GROWTH%
SHARESM
2012201320142015201620172018201920202021202220232024
2.004.004.005.007.007.009.0011.009.005.00–––
–100.00–25.0040.00–28.5722.22-18.18-44.44–––
-100.00-25.0075.0060.0028.5728.5733.3336.3655.5660.00–––
-2.00-1.003.003.002.002.003.004.005.003.003.003.003.00
-28.00-29.00-2.00-18.00-22.00-22.00-22.0022.00-5.006.00-12.00-3.00-11.00
-1,400.00-725.00-50.00-360.00-314.29-314.29-244.44200.00-55.56120.00–––
-29.00-50.00-24.00-20.00-23.00-22.00-20.0021.00-8.002.00-12.001.00-8.00
–72.41-52.00-16.6715.00-4.35-9.09-205.00-138.10-125.00-700.00-108.33-900.00
65.4865.4865.4865.4865.4858.3772.6380.1280.3280.6287.85108.1899.17
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Allmed Solutions generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Allmed Solutions retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Allmed Solutions's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Allmed Solutions has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Allmed Solutions's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Allmed Solutions stock margins

The Allmed Solutions margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Allmed Solutions. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Allmed Solutions.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
26.17 %
-296.53 %
-294.42 %
Jan 1, 2018
34.27 %
-247.10 %
-217.43 %
Jan 1, 2019
43.65 %
203.81 %
197.25 %
Jan 1, 2020
55.26 %
-60.99 %
-89.08 %
Jan 1, 2021
55.60 %
112.52 %
50.64 %
Jan 1, 2022
55.60 %
- %
- %
Jan 1, 2023
55.60 %
- %
- %
Jan 1, 2024
55.60 %
- %
- %

Allmed Solutions Stock Revenue, EBIT, Earnings per Share

The Allmed Solutions earnings per share therefore indicates how much revenue Allmed Solutions has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
0.13 ILS
-0.39 ILS
-0.39 ILS
Jan 1, 2018
0.13 ILS
-0.32 ILS
-0.28 ILS
Jan 1, 2019
0.14 ILS
0.28 ILS
0.27 ILS
Jan 1, 2020
0.12 ILS
-0.07 ILS
-0.11 ILS
Jan 1, 2021
0.07 ILS
0.08 ILS
0.03 ILS
Jan 1, 2022
0.00 ILS
-0.14 ILS
-0.14 ILS
Jan 1, 2023
0.00 ILS
-0.03 ILS
0.01 ILS
Jan 1, 2024
0.00 ILS
-0.11 ILS
-0.09 ILS

Allmed Solutions business model & stock analysis

Allmed Solutions Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Allmed Solutions historical P/E ratio, EBIT multiple, and P/S ratio

Allmed Solutions annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Allmed Solutions shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
58.37 M Stocks
Jan 1, 2018
72.63 M Stocks
Jan 1, 2019
80.12 M Stocks
Jan 1, 2020
80.32 M Stocks
Jan 1, 2021
80.62 M Stocks
Jan 1, 2022
87.85 M Stocks
Jan 1, 2023
108.18 M Stocks
Jan 1, 2024
99.17 M Stocks

Allmed Solutions stock splits

In Allmed Solutions's history, there have been no stock splits.
Price targets and forecasts for Allmed Solutions are not yet available.

Allmed Solutions shareholder structure

% Name
19.43225%
Milch Investment Holdings L.L.C.
Milch Investment Holdings L.L.C.
15.51927%
Filvest SCA
Filvest SCA
5.81484%
Ayalon Mutual Funds Ltd
Ayalon Mutual Funds Ltd
0.58045%
Milch (David Mark)
Milch (David Mark)

Allmed Solutions Executives and Management Board

13 members · avg. age 56 · 8 % women

SA

Mr. Shay Arotchas (44)

Vice President - Operations

745,000.00 ILS

Management

AR

Mr. Ariel Rubashkin (41)

Chief Executive Officer

737,000.00 ILS
ZK

Mr. Ziv Kalfon (46)

Vice President-Engineering & Technology

734,000.00 ILS
EK

Mr. Erez Keinan (36)

Vice President - Finance

–
DS

Mr. Daniel Spira (69)

Internal Auditor

–

Board of Directors

AA

Mr. Assaf Alperovitz (49)

Director · since 2012

2.04 M ILS
AN

Mr. Abraham Nahmias (66)

Chairman of the Board · since 2014

–
ST

Mr. Shai Tag (31)

Finance Director

–
EG

Dr. Ehud Geller (76)

Director

–
DM

DR. David Milch (64)

Director

–
RG

Ms. Rinat Gazit (53)

External Director

–

Frequently asked questions about Allmed Solutions

Converted at the current exchange rate, the Allmed Solutions share trades at 9.54 EUR (33.20 ILS).

No history available for Allmed Solutions.

The revenue cannot currently be calculated for Allmed Solutions.

The profit cannot currently be calculated for Allmed Solutions.

The P/E ratio cannot be calculated for Allmed Solutions at the moment.

The P/S cannot be calculated for Allmed Solutions currently.

The Eulerpool Quality Score for Allmed Solutions is 1/10.

The ISIN of Allmed Solutions is IL0011014508. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Allmed Solutions is ALMD.TA. The ticker symbol is used to trade Allmed Solutions shares on the stock exchange.

Allmed Solutions paid dividends every year for the past 0 years.

Allmed Solutions is assigned to the 'Health' sector.

The dividends of Allmed Solutions are distributed in ILS.

All fundamentals and in-depth analysis of Allmed Solutions

Our stock analysis for Allmed Solutions stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Allmed Solutions. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Allmed Solutions Stock
Allmed Solutions Revenue→
Allmed Solutions Stock
Allmed Solutions Net Income→
Allmed Solutions Stock
Allmed Solutions P/E→
Allmed Solutions Stock
Allmed Solutions P/S→
Allmed Solutions Stock
Allmed Solutions EBIT→
Allmed Solutions Stock
Allmed Solutions Dividend→
Allmed Solutions Stock
Allmed Solutions Directors Dealings→
Allmed Solutions Stock
Allmed Solutions Stocks→
Allmed Solutions Stock
Allmed Solutions Market capitalization→
Allmed Solutions Stock
Allmed Solutions Debt→
Allmed Solutions Stock
Allmed Solutions Liabilities→
Allmed Solutions Stock
Allmed Solutions Equity→
Allmed Solutions Stock
Allmed Solutions AAQS→
Allmed Solutions Stock
Allmed Solutions Employees→
Allmed Solutions Stock
Allmed Solutions ROE→
Allmed Solutions Stock
Allmed Solutions ROA→
Allmed Solutions Stock
Allmed Solutions ROCE→
Allmed Solutions Stock
Allmed Solutions News→
Allmed Solutions Stock
Allmed Solutions Analyst Price Targets→

Health Stocks

Allogene TherapeuticsAllmed Medical Products CoAlmirallAlligator BioscienceAlmoosa Health Company SJSCAllied BiotechAlnylam PharmaceuticalsAlliedAlpa LaboratoriesAlliance Healthcare GroupAlpha CognitionAllianca Saude e ParticipacoesAll Stocks A–Z →